We’re proud to share that inSoma Bio, Inc. has been selected to join the 2025 MedTech Innovator cohort, the world’s largest accelerator for medical device companies.
This recognition highlights the exceptional work of our team and underscores the potential of our technology to drive meaningful impact in healthcare. As part of a highly competitive program with an acceptance rate under 4%, we’re excited to join a global community of innovators shaping the future of medicine.
Stay tuned as we continue advancing regenerative solutions that transform patient outcomes.